Drugs normally target problematic proteins, but Peter Smith, Ph.D., believes his team at Remix Therapeutics can disrupt the process of a protein’s creation before it starts causing disease. Investors ...
London-based brand and design agency DixonBaxi has released REMIX, a 500-page hardback book capturing the vibrant, layered, ...
AI value is often associated with workforce reduction headlines. But nearly half of CIOs believe AI has not met their ROI expectations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback